Chemoinformaics analysis of (2E)-OCTA-2,7-DIEN-1-OL
| Molecular Weight | 126.199 | nRot | 5 |
| Heavy Atom Molecular Weight | 112.087 | nRig | 16 |
| Exact Molecular Weight | 126.104 | nRing | 0 |
| Solubility: LogS | -4.807 | nHRing | 0 |
| Solubility: LogP | 5.26 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 23.4971 |
| nHD | 1 | BPOL | 14.0449 |
| QED | 0.564 |
| Synth | 1.973 |
| Natural Product Likeliness | 0.245 |
| NR-PPAR-gamma | 0.971 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.035 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.817 |
| MDCK | 0.0000133 |
| BBB | 0.912 |
| PPB | 0.959934 |
| VDSS | 1.297 |
| FU | 0.0166757 |
| CYP1A2-inh | 0.432 |
| CYP1A2-sub | 0.212 |
| CYP2c19-inh | 0.367 |
| CYP2c19-sub | 0.059 |
| CYP2c9-inh | 0.19 |
| CYP2c9-sub | 0.942 |
| CYP2d6-inh | 0.027 |
| CYP2d6-sub | 0.265 |
| CYP3a4-inh | 0.168 |
| CYP3a4-sub | 0.055 |
| CL | 4.729 |
| T12 | 0.554 |
| hERG | 0.117 |
| Ames | 0.019 |
| ROA | 0.037 |
| SkinSen | 0.907 |
| Carcinogencity | 0.089 |
| EI | 0.971 |
| Respiratory | 0.924 |
| NR-Aromatase | 0.083 |
| Antiviral | No |
| Prediction | 0.95289 |